These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4050781)

  • 1. Selected health care maintenance policies in chronic dialysis centers.
    Dillingham MA; Anderson RJ
    Am J Kidney Dis; 1985 Oct; 6(4):237-40. PubMed ID: 4050781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with 184 cases of chronic hemodialysis].
    Lu ZY
    Zhonghua Yi Xue Za Zhi; 1989 Mar; 69(3):125-7, 10. PubMed ID: 2776052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.
    Changsirikulchai S; Domrongkitchaiporn S; Sirikulchayanonta V; Ongphiphadhanakul B; Kunkitti N; Stitchantrakul W; Radienahamed P
    J Med Assoc Thai; 2000 Oct; 83(10):1223-32. PubMed ID: 11143489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of an in-center daily hemodialysis program: results of two years of treatment.
    André MB; Rembold SM; Pereira CM; Lugon JR
    Am J Nephrol; 2002; 22(5-6):473-9. PubMed ID: 12381946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of the "adequate blood phosphorus" concept as a risk factor for hyperphosphatemia].
    Douthat WG; Alles A; Marinovich S; Tirado S; Peñalba A; Prudkin S
    Nefrologia; 2003; 23 Suppl 2():95-9. PubMed ID: 12778863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The best outcomes: are they in for-profit or not-for-profit units?
    Sadler JH
    Nephrol News Issues; 2000 Mar; 14(4):46-8. PubMed ID: 11075102
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in blood sample collection for determination of hemodialysis adequacy. Council on Renal Nutrition National Research Question Collaborative Study Group.
    Beto JA; Bansal VK; Ing TS; Daugirdas JT
    Am J Kidney Dis; 1998 Jan; 31(1):135-41. PubMed ID: 9428465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-care dialysis fits in with new economic challenges for providers.
    Usewicz MC
    Nephrol News Issues; 2011 Aug; 25(9):34-5. PubMed ID: 21905529
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological limitations of the ESRD Core Indicators Project: an ESRD network's experience with implementing an ESRD quality survey. Medical Review Board of the ESRD Network of New England.
    Owen WF; Meyer KB; Schmidt G; Alfred H
    Am J Kidney Dis; 1997 Sep; 30(3):349-55. PubMed ID: 9292562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal function substitutes. Technical and logistic orientation of the treatment].
    Legrain M; Rottembourg J
    Ann Med Interne (Paris); 1982; 133(8):611-24. PubMed ID: 6763488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of breath ammonia with blood urea nitrogen and creatinine during hemodialysis.
    Narasimhan LR; Goodman W; Patel CK
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4617-21. PubMed ID: 11296293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How dialysis is paid for: what the dialysis medical director should know, and why.
    Deoreo PB
    Semin Dial; 2008; 21(1):58-62. PubMed ID: 18086259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding financial risk models: Implicationsfor nephrology practices and dialysis centers.
    Cellini GL
    Nephrol News Issues; 2016 Mar; 30(3):26-8, 30-3. PubMed ID: 27169216
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemodialysis adequacy in Network 5: disparity between states and the role of center effects.
    Fink JC; Armistead N; Turner M; Gardner J; Light P
    Am J Kidney Dis; 1999 Jan; 33(1):97-104. PubMed ID: 9915273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
    Ramakrishnan K; Braunhofer P; Newsome B; Lubeck D; Wang S; Deuson J; Claxton AJ
    Adv Ther; 2014 Dec; 31(12):1272-86. PubMed ID: 25479935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
    Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
    Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health surveillance in the dialysis setting: opportunities and challenges for using electronic health records.
    Wise ME; Lovell C
    Semin Dial; 2013; 26(4):399-406. PubMed ID: 23721477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.